GRI Bio, Inc. (GRI)

0.4100 +0.0010 (+0.24%) At close: 04:00PM EDT

GRI Bio, Inc.

2223 Avenida de la Playa
Suite 208
LA Jolla, CA 92037
United States
619 400 1170
https://www.gribio.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 4

Key executives

Name	Title	Pay	Exercised	Year born
Dr. W. Marc Hertz Ph.D.	Co-Founder, CEO, President & Director	842.01k	N/A	1971
Ms. Leanne M. Kelly	CFO & Corporate Secretary	550.93k	N/A	1977
Dr. Albert Agro Ph.d.	Chief Medical Officer	461.1k	N/A	1965
Dr. Vipin Kumar Chaturvedi Ph.D.	Co-Founder & Chief Scientific Officer	N/A	N/A	1960

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase II clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 for the treatment of primary sclerosing cholangitis, and GRI-0729, which are in pre-clinical development. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

Corporate governance

GRI Bio, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.